Immunotherapy in Metastatic Colorectal Cancer: More Than Just MSI-H?
OncLive,
Jason Henry, MD For many patients, there is no greater sense of promise than cancer immunotherapy and it is often the first…
Jason Henry, MD For many patients, there is no greater sense of promise than cancer immunotherapy and it is often the first…
Updated results in seven patients with advanced uveal melanoma treated with CHEMOSAT and ipilimumab plus nivolumab show a…
Updated results in seven patients with advanced uveal melanoma treated with CHEMOSAT and ipilimumab plus nivolumab show a…
NEW YORK, Jan. 17, 2023 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the…